H.R. 8779 aims to prevent pharmacy benefit managers (PBMs) and pharmacies from being owned by the same company. This separation is intended to reduce potential conflicts of interest and promote fair competition in the pharmaceutical market, ultimately benefiting consumers by ensuring better access to medications and pricing.
Supporters of H.R. 8779 have praised the bill for its potential to increase transparency and fairness in the pharmaceutical industry. They argue that by prohibiting common ownership, the legislation could lead to lower drug prices and improved patient care, as it would eliminate incentives for PBMs to favor their own pharmacies over independent ones.
Critics of H.R. 8779 have expressed concerns that the bill may disrupt existing business models and could lead to unintended consequences, such as reduced access to medications for patients. Some argue that the legislation may not effectively address the root causes of high drug prices and could complicate the relationship between pharmacies and PBMs.
The analysis of H.R. 8779, which aims to prohibit pharmacy benefit managers and pharmacies from being under common ownership, reveals no direct industry overlaps between the sponsor Diana Harshbarger's top donor industries and the bill's subject matter. While there is significant lobbying activity in related areas, particularly from The Ferguson Group and Fresenius Kabi USA LLC, the absence of direct financial connections to pharmacy benefit managers or pharmacies suggests minimal risk of conflicts of interest. The $1,100,000 from Fresenius Kabi USA LLC, a pharmaceutical company, does not directly correlate with the bill's focus on ownership structures, indicating that the bill may not serve the interests of this donor directly.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| FRESENIUS KABI USA LLC | FRESENIUS KABI USA LLC | $1,100,000 |
| CONSEJO COORDINADOR EMPRESARIAL | IQOM STRATEGIC ADVISORS, LLC | $140,000 |
| IVANHOE ATLANTIC (FORMERLY HIGH POWER EXPLORATION INC.) | YORKTOWN SOLUTIONS | $120,000 |
| SKYRYSE, INC. | SKYRYSE, INC. | $70,000 |
| AIS HEALTHCARE | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $20,000 |
| THE FERGUSON GROUP, LLC FOR CAPE FEAR PUBLIC UTILITY AUTHORITY,NC | EARL STOCKDALE | undisclosed |
| THE FERGUSON GROUP, LLC ON BEHALF OF WEST COUNTY WASTEWATER DISTRICT, CA | EARL STOCKDALE | undisclosed |
| THE FERGUSON GROUP, LLC FOR CITY OF OCEANSIDE CA | EARL STOCKDALE | undisclosed |
| THE FERGUSON GROUP, LLC ON BEHALF OF WARD & SMITH (FOR BALD HEAD ISLAND) | EARL STOCKDALE | undisclosed |
| THE FERGUSON GROUP, LLC ON BEHALF OF WARD & SMITH, PA (FOR HOLDEN BEACH, NC) | EARL STOCKDALE | undisclosed |
| CORE POWER (US) INC. | INVARIANT LLC | undisclosed |
| ICON TECHNOLOGY, INC. | INVARIANT LLC | undisclosed |
| HUBBS-SEAWORLD RESEARCH INSTITUTE | HAMMER ASSOCIATES, LLC | undisclosed |
| THE POLICY SHOP LLC | JAVELIN ADVISORS LLC | undisclosed |
| NATIONAL ALLIANCE OF HEALTHCARE PURCHASER COALITIONS | NATIONAL ALLIANCE OF HEALTHCARE PURCHASER COALITIONS | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Diana Harshbarger, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
